About this episode
This episode discusses the impact of the reclassification of cannabis from Schedule I to Schedule III on research and regulations.
Send us Fan Mail NOT LEGAL ADVICE For decades, cannabis research in the U.S. was stifled by Schedule I restrictions, requiring high-security vaults, mountains of paperwork, and extremely limited supply chains. With Executive Order 14370, the landscape has shifted. Marijuana is moving to Schedule III, and the rules of the game have officially changed. In this episode of KLF Deep Dive, attorney-pharmacist Darshan Kulkarni breaks down the practical impact of this reclassification for...
People in this episode
Host: Darshan Kulkarni
Topics covered
- cannabis research
- legalization
- Schedule I
- Schedule III
- Executive Order
- pharmacy law
Keywords
- cannabis
- research
- Schedule I
- Schedule III
- Executive Order 14370
- legalization
- pharmacy
Mentioned in this episode
Organizations: Schedule I, Schedule III
Products: cannabis
Places: U.S.
More episodes of DarshanTalks Podcast
- Unlicensed Medical Advice & The Legal Battle Over Character.AI · May 18, 2026 · 15 min
- The New Era of Personal Consent Decrees · April 30, 2026 · 8 min
- Why Private Membership Associations Fail FDA Scrutiny · April 16, 2026 · 7 min
- The Hidden Reason Sites are Firing Recruiters · April 11, 2026 · 8 min
- Don’t Let Your PI Walk Away With Your Study · April 10, 2026 · 1 min
- Safe or Just "Not Dirty"? The Regulatory Gamble of Compounded Drugs · April 9, 2026 · 2 min
Explore listener stats, chart rankings, contacts and more on the DarshanTalks Podcast podcast page.